| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |